1887

oa South African Family Practice - Medifile : Pneumococcal vaccine for infants and toddlers

Volume 48, Issue 7
  • ISSN : 2078-6190

 

Abstract

The South African launch of Prevenar<sup>(R)</sup>, a new polyvalent conjugate vaccine, has resulted in many questions being posed by health care providers and parents alike. Without a government policy on the role of this vaccine and considering its high cost, there is much debate on its place in therapy, cost benefit and long term epidemiological effect. This article provides an overview of the vaccine, its known advantages, potential disadvantages, place in therapy and administration.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/mp_safp/48/7/EJC79965
2006-08-01
2016-12-10

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error